Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Benign skin adnexal tumors are more common than malignant ones, with trichoepithelioma and chondroid syringoma being the most frequent types.

Topical treatments led to hair regrowth in a man with linear morphea.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The exam tested knowledge on various skin-related topics for CME credit.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.